Ingevity Corporation
NYSE:NGVTChemicals - Specialty
+$0.81 today
- Market cap
- $1.97B
- Beta
- 1.19
- P/E (TTM)
- -20.0
- EPS (TTM)
- -$3.62
Volume 0.37M
Average 0.26M
NGVT Net Margin
Net income as a percentage of revenue, showing how much of each sales dollar becomes profit.
Ingevity CorporationNYSE: NGVT
Net Margin · Q3 FY2026 · quarter ended Sep 2026
Net margin widens to 16.2%
Net margin was 16.2% in Q3 FY2026, up 3.1 pp from a year earlier. On a trailing-twelve-month basis it was 5.3%, up 10.4 pp year over year. Over 3 fiscal years it narrowed by 27.0 pp.
Context
- Net margin widened in 1 of the last 3 fiscal years.
What to watch
Whether net margin reaches the consensus estimate from 2 analysts of 17.7% for the fiscal year ending Dec 2026, up from -14.3% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterSep 2026
- 16.2%+4.9 pp QoQ
- Last fiscal yearDec 2025
- -14.3%+16.3 pp YoY
- LTMSep 2026
- 5.3%+10.4 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +3.1 pp | +46.3 pp | +43.2 pp |
| 1 year | +16.3 pp | +32.0 pp | +15.7 pp |
| 3 years | -27.0 pp | +35.7 pp | +62.6 pp |
| 5 years | — | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- -14.3%
- Year-over-year change
- +16.3pp
| Period | Period end | Net Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | -14.3% | +16.3pp |
| FY2024 | 2024-12-31 | -30.6% | -30.3pp |
| FY2023 | 2023-12-31 | -0.3% | -13.0pp |
| FY2022 | 2022-12-31 | 12.7% | +4.2pp |
| FY2021 | 2021-12-31 | 8.5% | — |
Net Margin vs competitors
How NGVT compares with its peers on the latest reported figures
- NGVT's LTM Sep 2026 net margin of 5.3% is the 4th highest of the 10 companies compared; the peer median is 2.8%.
- Its year-over-year change of +10.4 pp is the 3rd highest of 10, against a peer median of +5.5 pp.
- Over three fiscal years its change of -27.0 pp compares with a peer median of -10.7 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
ELVRElevra Lithium Limited | FY2025 | 30.1% | +161.9 pp | — |
| LTM Apr 2026 | 7.6% | +8.7 pp | -6.6 pp | |
| LTM Jun 2026 | 6.6% | +5.5 pp | -0.2 pp | |
| LTM Sep 2026 | 5.3% | +10.4 pp | -27.0 pp | |
| LTM Sep 2026 | 4.8% | +5.3 pp | +0.7 pp | |
| LTM Jun 2026 | 2.8% | +48.8 pp | -85.1 pp | |
| LTM Jun 2026 | -2.1% | -1.9 pp | -14.8 pp | |
AAUCAllied Gold Corporation | LTM Jun 2026 | -4.2% | +9.3 pp | -2.8 pp |
| LTM Jun 2026 | -5.2% | +1.9 pp | -15.1 pp | |
| LTM Mar 2026 | -72.9% | -80.9 pp | -77.3 pp | |
| FY2025 | — | — | — | |
| Peer median (excluding NGVT) | 2.8% | +5.5 pp | -10.7 pp | |
Competitors are the stored peer set for NGVT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1.39B | 1.67B | 1.69B | 1.41B | 1.17B |
| Cost of Revenue | 878.7M | 1.1B | 1.22B | 951.7M | 706.1M |
| Gross Profit | 512.8M | 570.1M | 471.9M | 454.7M | 461.5M |
| Gross Margin | 36.9% | 34.2% | 27.9% | 32.3% | 39.5% |
| Research & Development | 26.3M | 30.3M | 31.8M | 28.1M | 28.4M |
| Selling, General & Admin | 179.3M | 198.8M | 183.7M | 166.7M | 171.2M |
| Operating Expenses | 205.6M | 229.1M | 215.5M | 194.8M | 199.6M |
| Depreciation & Amortization | 109.9M | 108.8M | 122.8M | 108.3M | 106.4M |
| EBITDA | 324.4M | 440.2M | 206M | (329.5M) | 37.4M |
| EBITDA Margin | 23.3% | 26.4% | 12.2% | -23.4% | 3.2% |
| Operating Income | 307.2M | 341M | 256.4M | 259.9M | 261.9M |
| Operating Margin | 22.1% | 20.4% | 15.2% | 18.5% | 22.4% |
| Interest Income | 4M | 5.8M | 6.3M | 6.9M | 4.4M |
| Interest Expense | 51.7M | 61.8M | 93.3M | 97.8M | 77.1M |
| Other Income / Expenses | (144.4M) | (71.4M) | (266.5M) | (795.5M) | (404M) |
| Income Before Tax | 162.8M | 269.6M | (10.1M) | (535.6M) | (142.1M) |
| Pre-Tax Margin | 11.7% | 16.2% | -0.6% | -38.1% | -12.2% |
| Income Tax Expense | 44.7M | 58M | (4.7M) | (105.3M) | 8.2M |
| Net Income | 118.1M | 211.6M | (5.4M) | (430.3M) | (167.1M) |
| Net Margin | 8.5% | 12.7% | -0.3% | -30.6% | -14.3% |
| EPS (Basic) | 2.97 | 5.50 | (0.15) | (11.85) | (4.61) |
| EPS (Diluted) | 2.95 | 5.50 | (0.15) | (11.85) | (4.61) |
| Weighted Avg Shares | 39.8M | 38.47M | 36.5M | 36.32M | 36.2M |
| Weighted Avg Shares (Diluted) | 40.06M | 38.47M | 36.5M | 36.32M | 36.2M |
Ingevity Corporation
NYSE:NGVT
Intrinsic Alpha fair value
Locked
Current Price
$58.31
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.